Evaluation Of The Current Knowledge Limitations In Breast Cancer Research

April 2019

Cancer

Country of origin: UK

A gap analysis was conducted to determine which areas of breast cancer research, if targeted by researchers and funders, could produce the greatest impact on patients.

Fifty six Breast Cancer Campaign grant holders and prominent UK breast cancer researchers participated in a gap analysis of current breast cancer research. Before, during and following the meeting, groups in seven key research areas participated in cycles of presentation, literature review and discussion. Summary papers were prepared by each group and collated into a position paper highlighting the research gaps, with recommendations for action.

Gaps were identified in all seven themes. General barriers to progress were lack of financial and practical resources, and poor collaboration between disciplines. Critical gaps in each theme included (1) genetics: knowledge of genetic changes, their effects and interactions; (2) initiation of breast cancer: how developmental signalling pathways cause ductal elongation and branching at the cellular level and influence stem cell dynamics, and how their disruption initiates tumour formation; (3) progression of breast cancer: deciphering the intracellular and extracellular regulators of early progression, tumour growth, angiogenesis and metastasis; (4) therapies and targets: understanding who develops advanced disease; (5) disease markers: incorporating intelligent trial design into all studies to ensure new treatments are tested in patient groups stratified using biomarkers; (6) prevention: strategies to prevent oestrogen-receptor negative tumours and the long-term effects of chemoprevention for oestrogen-receptor positive tumours; (7) psychosocial aspects of cancer: the use of appropriate psychosocial interventions, and the personal impact of all stages of the disease among patients from a range of ethnic and demographic backgrounds.

Through recommendations to address these gaps with future research , the long-term benefits to patients will include: better estimation of risk in families with breast cancer and strategies to reduce risk; better prediction of drug response and patient prognosis; improved tailoring of treatments to patient subgroups and development of new therapeutic approaches; earlier initiation of treatment; more effective use of resources for screening populations; an enhanced experience for people with or at risk of breast cancer and their families. The challenge to funding bodies and researchers in all disciplines is to focus on these gaps and to drive advances in knowledge into improvements in patient care.

The complete article is available online.

Resources

Reassessing Carcinogenic HPV Types May 2019 Virtually all cases of cervical cancer are caused by persistent infections with a restricted set of human papillomaviruses...
Sebaceous Carcinoma Of The Skin Of The Breast: Case Report May 2019 Sebaceous gland tumours are rare and their presence should be considered as a marker for Muir-Torre Syndrome, alerting to...
Cervical screening website May 2019 The British Society for Colposcopy and Cervical Pathology (BSCCP) has a website able to send online mail shots and provide...
Report on deaths from head and neck cancers in England April 2019 Public Health England’s National End of Life Care Intelligence Network has published a new report examining who dies from...
1 in 5 people get skin cancer April 2019 Skin cancer is one of the most common forms of cancer and can appear anywhere on the skin. Non-melanoma skin cancers, like...
Online Tool for Calculating Colorectal Cancer Risk April 2019 An online tool for calculating colorectal cancer risk in men and women age 50 or older was launched recently, based on a...
The Lancet March 2019 The Lancet

Available for both iPad & iPhone, the new and improved The Lancet app is free to download and offers...
Keeping Up To Date March 2019 The late diagnosis of almost all types of cancer usually means the disease has already spread within the body, making it...
inPractice® Oncology. March 2019 inPractice® Oncology is the only point-of-care clinical reference designed to meet the unique needs of specialists. Full...
Researchers in bowel cancer discovery February 2019 Scientists have discovered how genes cause bowel cancer cells to become resistant to treatments used against the disease....
Search by Keyword